Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TENOFOVIR DISOPROXIL FUMARATE, with a corresponding US DMF Number 31461.
Remarkably, this DMF maintains an Active status since its submission on May 03, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 07, 2017, and payment made on May 12, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II